Immune Checkpoint Inhibitors and Inflammatory Myopathies: Data from the US Food and Drug Administration Adverse Event Reporting System

被引：0
|
作者：
Pundole, Xerxes [1 ]
Shah, Mohsin [1 ]
Abdel-Wahab, Noha [1 ]
Suarez-Almazor, Maria [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Sect Rheumatol & Clin Immunol, Dept Gen Internal Med, Houston, TX 77030 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
850
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019
    Shaokui Wei
    Manette T. Niu
    Graça M. Dores
    Drugs - Real World Outcomes, 2021, 8 : 253 - 262
  • [42] Hypnotics and infections: disproportionality analysis of the US Food & Drug Administration adverse event reporting system database
    Meng, Long
    Huang, Jing
    He, Qin
    Zhao, Yibei
    Zhao, Wenlong
    Tan, Juntao
    Sun, Shusen
    Yang, Junqing
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2022, 18 (09): : 2229 - 2235
  • [43] Sex differences in immune-related adverse events with immune checkpoint inhibitors: data mining of the FDA adverse event reporting system
    Chen Chen
    Chenyu Zhang
    Ziyan Jin
    Bin WU
    Ting XU
    International Journal of Clinical Pharmacy, 2022, 44 : 689 - 697
  • [44] SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system
    Benedetta Maria Bonora
    Emanuel Raschi
    Angelo Avogaro
    Gian Paolo Fadini
    Cardiovascular Diabetology, 20
  • [45] Hemolytic anemia following alectinib reported to the US Food and Drug Administration Adverse Event Reporting System
    Dores, Graca M.
    Nayernama, Afrouz
    Cheng, Connie
    Moureaud, Charlotte
    Jones, S. Christopher
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (04) : E129 - E132
  • [46] Sex differences in immune-related adverse events with immune checkpoint inhibitors: data mining of the FDA adverse event reporting system
    Chen, Chen
    Zhang, Chenyu
    Jin, Ziyan
    Wu, Bin
    Xu, Ting
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (03) : 689 - 697
  • [47] SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system
    Bonora, Benedetta Maria
    Raschi, Emanuel
    Avogaro, Angelo
    Fadini, Gian Paolo
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [48] Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration
    Fei Liang
    Sheng Zhang
    Qin Wang
    Wenfeng Li
    BMC Cancer, 20
  • [49] Stimulated Reporting: The Impact of US Food and Drug Administration-Issued Alerts on the Adverse Event Reporting System (FAERS)
    Hoffman, Keith B.
    Demakas, Andrea R.
    Dimbil, Mo
    Tatonetti, Nicholas P.
    Erdman, Colin B.
    DRUG SAFETY, 2014, 37 (11) : 971 - 980
  • [50] Stimulated Reporting: The Impact of US Food and Drug Administration-Issued Alerts on the Adverse Event Reporting System (FAERS)
    Keith B. Hoffman
    Andrea R. Demakas
    Mo Dimbil
    Nicholas P. Tatonetti
    Colin B. Erdman
    Drug Safety, 2014, 37 : 971 - 980
12345